NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,101,222 | +33.4% | 73,759 | +44.3% | 0.03% | +26.1% |
| Q3 2023 | $825,782 | +18.1% | 51,132 | +203.6% | 0.02% | +35.3% |
| Q2 2023 | $698,985 | -34.8% | 16,843 | -5.5% | 0.02% | -41.4% |
| Q1 2023 | $1,072,056 | -19.4% | 17,826 | -1.6% | 0.03% | -23.7% |
| Q4 2022 | $1,329,469 | -1.4% | 18,125 | +2.1% | 0.04% | -13.6% |
| Q3 2022 | $1,349,000 | -11.1% | 17,757 | -18.7% | 0.04% | 0.0% |
| Q2 2022 | $1,518,000 | -42.8% | 21,846 | -31.8% | 0.04% | -17.0% |
| Q1 2022 | $2,654,000 | +1.4% | 32,035 | -8.1% | 0.05% | +3.9% |
| Q4 2021 | $2,617,000 | +62.3% | 34,861 | +151.2% | 0.05% | +24.4% |
| Q3 2021 | $1,612,000 | -31.8% | 13,876 | +30.2% | 0.04% | -45.3% |
| Q2 2021 | $2,365,000 | +35.9% | 10,661 | -19.0% | 0.08% | +15.4% |
| Q1 2021 | $1,740,000 | +37.2% | 13,166 | +79.6% | 0.06% | +10.2% |
| Q4 2020 | $1,268,000 | +22.2% | 7,329 | -21.4% | 0.06% | 0.0% |
| Q3 2020 | $1,038,000 | +189.9% | 9,326 | +54.3% | 0.06% | 0.0% |
| Q2 2020 | $358,000 | +216.8% | 6,044 | +261.1% | 0.06% | -3.3% |
| Q1 2020 | $113,000 | +135.4% | 1,674 | +193.2% | 0.06% | +510.0% |
| Q4 2019 | $48,000 | – | 571 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |